| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/18/1992 | CA2057646A1 Benzodiazepinone |
| 06/17/1992 | EP0490667A2 HIV protease inhibitors |
| 06/17/1992 | EP0490598A1 Antitumoral and antiviral compound |
| 06/17/1992 | EP0490450A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastrointestinal medicines |
| 06/17/1992 | EP0490434A1 Labelled, modified oligonucleotides |
| 06/17/1992 | EP0490383A2 Peptides of the HIV-gag protein, their preparation and use |
| 06/17/1992 | EP0490311A1 Derivatives of 10,11,12,13-tetra-hydrodesmycosin, processes for preparation, and use thereof in obtaining pharmaceuticals |
| 06/17/1992 | EP0490305A2 Microspheres for ophthalmic use |
| 06/17/1992 | EP0489733A1 Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents |
| 06/17/1992 | EP0456843A4 Bornyl and isobornyl carboxylic esters of condensed tetrahydroquinoxalines |
| 06/17/1992 | CN1061972A Process for preparing hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
| 06/17/1992 | CN1061907A Suspendible composition and process for prepairng same |
| 06/16/1992 | US5122535 Method of solubilizing melatonine in water |
| 06/16/1992 | US5122301 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 06/16/1992 | CA1303613C Substituted indoloquinoxalines |
| 06/16/1992 | CA1303525C Rotavirus reassortant vaccine |
| 06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
| 06/15/1992 | WO1992010204A1 Lectins in probiosis |
| 06/15/1992 | CA2098305A1 Lectins in probiosis |
| 06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
| 06/13/1992 | CA2055522A1 Microspheres for ophthalmic use |
| 06/12/1992 | WO1992010502A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines |
| 06/12/1992 | CA2075812A1 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines |
| 06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
| 06/11/1992 | WO1992009597A1 Optical isomers of 7-[3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 06/11/1992 | WO1992009596A1 Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 06/11/1992 | WO1992009557A1 Benzenedimethanol suitable for micronisation |
| 06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
| 06/11/1992 | WO1992009291A1 Treatment of topical infections |
| 06/11/1992 | WO1991015498A3 Nucleoside derivatives |
| 06/11/1992 | CA2097334A1 Treatment of topical infections |
| 06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/10/1992 | EP0489308A1 Partricin derivatives |
| 06/09/1992 | US5120842 Immunosuppresive activity, antitumor agents, fungicides |
| 06/09/1992 | US5120735 Synergistic mixture of miconazole, ketoconazole or fluconazole and N-4-tertbutylbenzyl-N-methyl-1-naphthalenemethylamine |
| 06/09/1992 | US5120728 Antibacterial agents |
| 06/09/1992 | US5120727 Rapamycin dimers |
| 06/09/1992 | US5120725 Antibody inhibitors |
| 06/09/1992 | US5120717 Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodeficiency syndrome |
| 06/09/1992 | US5120639 Neutralizing herpes simplex virus DNA polymerase using an antibody obtained from a specified decapeptide and measuring amount of bound antibody |
| 06/09/1992 | US5120530 Fungicides, water-insoluble cationic copolymers; chemical resistance, durability |
| 06/09/1992 | CA1303031C Pyrimidine derivatives |
| 06/09/1992 | CA1303028C Metal complexes of n-methyl-11-aza-10-deoxo-10- dihydroerythromycina or 11-aza-10-deoxo-10- dihydroerythromycin a, method for the manufacture thereof and their use in the manufacture of pharmaceuticals |
| 06/09/1992 | CA1302926C Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent |
| 06/09/1992 | CA1302883C Method of preparing toxoid |
| 06/09/1992 | CA1302882C Vaccines and immunoglobulin g-containing preparations active against pseudomonas aeruginosa |
| 06/08/1992 | CA2056970A1 Antitumoral and antiviral compound |
| 06/06/1992 | WO1992010516A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
| 06/06/1992 | CA2095725A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics and a process for preparing them |
| 06/03/1992 | EP0488589A1 Process for producing kappa-casein glycomacropeptides |
| 06/03/1992 | EP0488227A2 Optically active pyridobenzoxazine derivatives |
| 06/03/1992 | EP0488169A1 Beta-Hydroxyethylamines with a 1,1-disubstituted cyclopropyl-group, process for their preparation and use |
| 06/03/1992 | EP0488041A2 A pharmaceutical composition for cytomegalovirus infection |
| 06/03/1992 | EP0487996A2 Cephalosporins substituted in position 3, process for their preparation and their use as medicine |
| 06/03/1992 | EP0487718A1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety |
| 06/03/1992 | EP0487623A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1992 | EP0487525A1 Tuftsin analogs |
| 06/03/1992 | CN1061602A Process for preparing 7-acyl-3-(substituted carbambytoxy) cephem compound |
| 06/02/1992 | USRE33948 Bactericides, animal growth regulators |
| 06/02/1992 | US5118789 Obtained from larvae injured in body wall |
| 06/02/1992 | US5118705 Water soluble salts of purpuromycin and pharmaceutical formulations thereof |
| 06/02/1992 | US5118698 Pharmaceutical preparations |
| 06/02/1992 | US5118677 For treating transplant rejection, host vs. draft disease, autoimmune diseases and inflammations; antibody inhibitors |
| 06/02/1992 | CA1302407C Process for the preparation of macrolide compounds |
| 06/02/1992 | CA1302402C Compounds |
| 06/02/1992 | CA1302280C Topical antimicrobial pharmaceutical compositions and methods |
| 06/02/1992 | CA1302274C Antibacterial drugs for fish |
| 06/02/1992 | CA1302253C Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
| 05/29/1992 | WO1992008789A1 Measles virus recombinant poxvirus vaccine |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008717A1 Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
| 05/29/1992 | WO1992008701A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008700A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008699A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008698A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008688A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008486A1 Avirulent microbes and uses therefor: salmonella typhi |
| 05/29/1992 | WO1992008484A1 Mycobacterium vaccae in the treatment of uveitis |
| 05/29/1992 | WO1992008463A1 Direct compression method for preparing pills having cephalosporanic acid derivatives |
| 05/29/1992 | CA2056311A1 .beta.-hydroxyethylamines having a 1,1-disubstituted cyclopropyl radical,a p process for their preparation and their use |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/29/1992 | CA2056103A1 3-substituted cephalosporins, process for their preparation and their use as medicaments |
| 05/28/1992 | WO1992009606A1 Optically active thiazoloisoindolinone derivatives with an antiviral action |
| 05/28/1992 | WO1992009287A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections |
| 05/28/1992 | CA2097087A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections |
| 05/28/1992 | CA2095255A1 Optically-active thiazoloisoindolinone derivatives with anti-viral action |
| 05/27/1992 | WO1992009269A1 Oral spiramycine formulations and method for preparing same |
| 05/27/1992 | EP0487411A1 Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments |
| 05/27/1992 | EP0487270A2 HIV protease inhibitors having polyether substituents |
| 05/27/1992 | EP0486964A2 S(+)-Phenyl-alkanoic acids and alpha-hydroxy-alkanoic acids containing complexes |
| 05/27/1992 | EP0486948A2 Retroviral protease inhibiting compounds |
| 05/27/1992 | EP0486809A2 Use of suramin against TNF-related diseases |
| 05/27/1992 | CN1061414A Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 05/27/1992 | CN1061405A Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids |
| 05/27/1992 | CN1061404A Complexes containing s(+) phenyl alkane acids and alpha-amino acids |